Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
767 Medicinal Charcoal BP EP USP Pharma Grade represents a highly purified form of activated carbon designed for use in pharmaceutical, laboratory, and clinical settings, manufactured to meet stringent British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards. This charcoal plays a critical role in the purification and detoxification processes, whether in emergency rooms treating poisonings or in advanced laboratory settings analyzing chemical compounds. Activated medicinal charcoal comes as a fine powder, produced from natural raw materials like wood, coconut shells, or peat. Activation through high temperature steam or chemical processes creates a porous structure, giving it exceptional adsorptive properties for removing contaminants and toxins at a molecular level. Its applications in human health and analytical chemistry reflect a significant scientific understanding of surface chemistry, chemical binding, and filtration.
This grade of medicinal charcoal shows up most often in powder form, preferred for its high surface area and easy dispersion in solution for clinical use. Pellet, flake, and granular forms also exist, each offering specific benefits in handling and dosing. In emergencies, medical professionals rely on finely powdered 767 Medicinal Charcoal mixed with water or liquid carriers to create a slurry taken orally or administered through gastric tubes. Some pharmaceutical manufacturers use it in capsules, tablets, or as granules for direct ingestion. Handling depends on the specific form: powder flows easily yet can form dust; pellets reduce airborne particles but may not disperse as rapidly in solution. While it has no true liquid, pearl, or crystal forms, it dissolves in water for suspension rather than true dissolution at the molecular level, reflecting its insolubility yet ample utility in medical suspension delivery.
The molecular structure of 767 Medicinal Charcoal consists primarily of elemental carbon, often denoted by the simple molecular formula C. Typically, it is odorless, tasteless, and black, with an amorphous, microcrystalline structure packed with internal pores. These pores provide a massive surface area—sometimes up to 1500 square meters per gram—enabling a high adsorption capacity for toxins, gases, and liquids. Density for the powder generally falls between 0.2 to 0.5 g/cm3, depending on packing and activation method. Typical surface areas measured by the Brunauer-Emmett-Teller (BET) method yield values exceeding 1000 m2/g. High purity means low ash content, minimal heavy metal contamination, and strict adherence to pharmacopeia standards for moisture and particle size. Thermal stability ensures no hazardous breakdown under normal operating conditions.
Industry and clinical standards demand deep documentation, with key specifications including moisture typically below 10%, acid-soluble substances limited to pharmacopeial thresholds, and pH values in neutral to slightly alkaline range, often between 5 and 10. Heavy metal limits, such as for lead, arsenic, and mercury, are set extremely low considering pharmaceutical uses. The powder passes through a 200 mesh sieve for consistent particle size suitable for gastrointestinal absorption and suspension. Tests for adsorption capacity, such as methylene blue adsorption, provide benchmarks for performance: many samples show adsorption of up to 140 mg methylene blue per gram. Volatile matter content, ash content, and loss on drying remain tightly controlled. Relevant HS Code for medicinal charcoal is 3802.10, defining its status as activated carbon, activated natural mineral products, and their derivatives, suited for customs and trade documentation.
Medicinal charcoal, at the pharma grade level, carries a high safety profile when used as directed but demands respect for inhalation risks and safe handling. Its main hazard arises from airborne particulate; fine powder poses inhalation risk, potentially irritating mucous membranes or causing respiratory discomfort. Appropriate protective measures—such as dust masks, goggles, and local ventilation—should always come into play during handling in manufacturing or compounding pharmacies. Charcoal itself is chemically inert, non-flammable under standard storage, and does not undergo hazardous reactions with water or most chemicals. Ingestion of medical charcoal under clinical supervision is broadly considered safe for acute poisoning scenarios, though it absorbs not only toxins but also vitamins or medications, so physicians must assess risks of drug binding or interactions. Bulk storage requires dry, sealed containers, away from oxidants, acids, or moisture that might degrade surface activity or contaminate the product with mold or bacteria. No chronic toxicity has been associated with properly refined, contaminant-free material. Regulatory authorities nevertheless demand full traceability of raw materials, strict batch control, and continuous purity checks to prevent inadvertent patient exposure to harmful substances. Charcoal produced from contaminated or subpar feedstock presents hazards—such as heavy metals or polycyclic aromatic hydrocarbons (PAHs)—so pharma grade sourcing and certification carry real importance for patient and staff safety.
The choice of raw materials defines product quality from the outset. Manufacturers turn to renewable sources such as fine-grade coconut shell, wood chips, or peat, processed through carbonization at high temperatures to form char, then treated with steam or chemical agents in the activation phase. Rigorous process control eliminates residual tars, creosotes, and metal contaminants—scrutiny of supply inputs remains a cornerstone of pharmaceutical carbon production. Testing for biological contaminants like bacteria or endotoxins reflects heightened safety needs in pharmaceutical use compared to industrial charcoal. Modern facilities maintain GMP-compliant clean-room environments, with strict environmental controls to prevent ambient contamination during filling, packaging, and shipping. Quality control laboratories carry out every relevant pharmacopeial assay to guarantee consistency and purity. Each batch receives a unique identification code, with certificates of analysis confirming specifications from particle size to adsorptive activity. Without this level of oversight, the final product risks failing critical performance, purity, or safety benchmarks, potentially culminating in regulatory recall or legal liability. I’ve seen firsthand how granular tracking from raw material lots to finished product batches saves time and reputational harm in regulated supply chains.
Effective use of 767 Medicinal Charcoal BP EP USP Pharma Grade depends on clear labeling, professional training, and understanding of its binding properties in clinical and manufacturing fields. Hospitals, clinics, and poison control centers rely on prompt access to high-purity charcoal in cases of drug or chemical overdose. Pharmacists must document exact dosing and compatibility with co-administered medications, taking steps to avoid complications with other oral drugs whose absorption could fall. In laboratory analysis, this grade of charcoal is essential for purification, decolorization, and removal of organic impurities in biological or chemical samples. The food and beverage industry, subject to residue limits and purity rules, sources only high-grade medicinal charcoal to avoid introducing contaminants. Tackling supply chain issues starts with shareholder education, transparent supplier vetting, and rigorous laboratory assays. Looking forward, the drive for greener manufacturing and fully traceable carbon-neutral raw materials will keep the pharma grade medicinal charcoal sector focused on sustainable sourcing, worker safety, and product integrity—each a building block for a healthier society and reliable pharmaceutical supply systems.
767 Medicinal Charcoal BP EP USP Pharma Grade production lines align with BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) monographs. These standards provide detailed testing methods and safety requirements, including limits for foreign substances and procedures for measuring chromatographic purity and adsorption capacity. Practitioner organizations like the American Academy of Clinical Toxicology and the World Health Organization set additional practical guidelines for clinical use, emphasizing swift administration and clear documentation. The World Customs Organization assigns HS Code 3802.10, streamlining import-export processes and enforcing international norms for product classification. Scientific studies in journals such as the Journal of Clinical Toxicology and the International Journal of Pharmaceutical Sciences confirm the continuing role of high-quality activated charcoal in drug overdose management and laboratory purification. These guidelines and peer-reviewed sources reinforce the safety, performance, and regulatory compliance essential in supplying 767 Medicinal Charcoal BP EP USP Pharma Grade to medical, scientific, and industrial users worldwide.
Chengguan District, Lanzhou, Gansu, China
